Although AKAP12 binding does not suppress intrinsic Src tyrosine kinase activity it suppresses Src-mediated MEK-ERK1/2, STAT3, and PI3K/AKT signaling that controls oncogenic progression parameters such as tumor invasiveness, anchorage-independent growth, and survival [8, 13]. The gene discussed is AKT1; the disease is neoplasm.